HealthCare Global Enterprises (NSE:HCG) Tax Expense: ₹41 Mil (TTM As of Mar. 2026)


NSE:HCG HealthCare Global Enterprises Ltd NSE:HCG
85 GF Score
Price ₹652.60
GF Value ₹578.25
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is HealthCare Global Enterprises Tax Expense?

HealthCare Global Enterprises NSE:HCG -0.34% 85 Tax Expense is ₹41 Mil as of Mar. 2026. GuruFocus rates NSE:HCG with a GF Score™ of 85/100 and a GF Value™ of ₹578.25 (Modestly Overvalued). The stock has 2 warning signs investors should review.

HealthCare Global Enterprises's tax expense for the months ended in Mar. 2026 was ₹-28 Mil. Its tax expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹41 Mil.


HealthCare Global Enterprises  (NSE:HCG) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


HealthCare Global Enterprises Tax Expense Related Terms


HealthCare Global Enterprises Tax Expense Historical Data

* Premium members only.

The historical data trend for HealthCare Global Enterprises's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthCare Global Enterprises Tax Expense Chart

HealthCare Global Enterprises Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 488.47 272.50 263.95 81.30 41.40

HealthCare Global Enterprises Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.50 59.40 -8.40 18.30 -27.90
NSE:HCG
85GF Score
HealthCare Global Enterprises Ltd NSE:HCG
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthCare Global Enterprises Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of ₹41 Mil mean?
HealthCare Global Enterprises (NSE:HCG) has a Tax Expense of ₹41 Mil as of Mar. 2026. Tax expense is the amount of tax the company pays in an accounting period. View historical data on HealthCare Global Enterprises and its competitors.
Is HealthCare Global Enterprises' Tax Expense too high?
HealthCare Global Enterprises' current Tax Expense is ₹41 Mil. Overall, HealthCare Global Enterprises has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HealthCare Global Enterprises' Tax Expense compare to HCA and THC?
HealthCare Global Enterprises' Tax Expense of ₹41 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Healthcare Providers & Services company?
A good Tax Expense depends on the Healthcare Providers & Services industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on HealthCare Global Enterprises and its competitors. HealthCare Global Enterprises's current Tax Expense is ₹41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthCare Global Enterprises stock overvalued right now?
Based on GuruFocus' analysis, HealthCare Global Enterprises (NSE:HCG) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹578.25, compared to a current price of ₹652.60 — trading 12.9% above its estimated fair value. The current Tax Expense is ₹41 Mil. HealthCare Global Enterprises' overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For HealthCare Global Enterprises (NSE:HCG), the current Tax Expense is ₹41 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?

Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued. The current stock price of ₹652.60 is trading 12.9% above its estimated GF Value™ of ₹578.25. GuruFocus considers HealthCare Global Enterprises to be Modestly Overvalued.

Key valuation signals for NSE:HCG:

  • Tax Expense: ₹41 Mil
  • GF Value™: ₹578.25 vs. price of ₹652.60 (12.9% above fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


HealthCare Global Enterprises Business Description

Other Exchanges 539787:India
Address Mission Road, No. 3, Ground Floor, Tower Block, Unity Building Complex, Bengaluru, KA, IND, 560027
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
85GF Score

Get the complete analysis for NSE:HCG

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹652.60
Price
₹578.25
GF Value